Perhexiline: Clinical Trials

3 trials of Perhexiline, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown, 1 withdrawn. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Unknown 1, Withdrawn 1
Phase 22Completed 1, Unknown 1

Follow Perhexiline: new trials by email Literature Review of Perhexiline trials Research Report on Perhexiline

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy
Perhexiline, Placebo marked PEXSIG - Myocardial Reperfusion Injury, Cardiac Output, Low
Phase 2 / Phase 3UnknownUniversity Hospital Birmingham2202009-10-012011-08-11
Metabolic Support With Perhexiline to Protect Myocardium Undergoing Coronary Artery Surgery
Perhexiline, Placebo marked PEXSIG - Myocardial Reperfusion Injury, Cardiac Output, Low
Phase 2 / Phase 3CompletedUniversity Hospital Birmingham2902007-02-012010-05-20
Efficacy, Safety, and Tolerability of Perhexiline in Subjects With Hypertrophic Cardiomyopathy and Heart Failure
Perhexiline, Placebo - Hypertrophic Cardiomyopathy
Phase 3WithdrawnHeart Metabolics Limited2017-07-14

Conditions studied

Cardiac Output, Low (2)  ·  Myocardial Reperfusion Injury (2)  ·  Aortic Valve Stenosis (1)  ·  Cardiomyopathy, Hypertrophic (1)  ·  Hypertrophy, Left Ventricular (1)

Sponsors

University Hospital Birmingham (2)  ·  Heart Metabolics Limited (1)

Countries

United Kingdom (2)

Top investigators

Domeinco Pagano, MD FRCS (2)

Results publications

PMID 24948413